Large-cap Health Care company AbbVie has logged a -0.3% change today on a trading volume of 1,945,541. The average volume for the stock is 4,537,885.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. Based in North Chicago, United States the company has 50,000 full time employees and a market cap of $262,277,611,520. AbbVie currently offers its equity investors a dividend that yields 3.9% per year.
The company is now trading -12.55% away from its average analyst target price of $169.92 per share. The 24 analysts following the stock have set target prices ranging from $135.0 to $205.0, and on average give AbbVie a rating of buy.
Over the last 52 weeks, ABBV stock has risen 7.0%, which amounts to a -16.0% difference compared to the S&P 500. The stock's 52 week high is $168.11 whereas its 52 week low is $130.96 per share. Based on AbbVie's average net margin growth of 1.2% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023-02-17 | 58,054,000 | 11,836,000 | 20 | -4.76 |
2022-02-18 | 56,197,000 | 11,542,000 | 21 | 110.0 |
2021-02-19 | 45,804,000 | 4,616,000 | 10 | -58.33 |
2020-02-21 | 33,266,000 | 7,882,000 | 24 | 41.18 |
2019-02-27 | 32,753,000 | 5,687,000 | 17 | -10.53 |
2018-02-16 | 28,216,000 | 5,309,000 | 19 |